Literature DB >> 9311731

Predictive testing for retinoblastoma comes of age.

B L Gallie.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9311731      PMCID： PMC1715909          DOI： 10.1086/514861

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  10 in total

1.  Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; M Gerick; B Brandt; U Oelschläger; B Lorenz; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

2.  Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.

Authors:  H Z Noorani; H N Khan; B L Gallie; A S Detsky
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

3.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

4.  Segregation analysis in hereditary retinoblastoma.

Authors:  C Bonaïti-Pellié; M L Briard-Guillemot
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

5.  Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma.

Authors:  R Godbout; T P Dryja; J Squire; B L Gallie; R A Phillips
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

6.  Identification of germline and somatic mutations affecting the retinoblastoma gene.

Authors:  J M Dunn; R A Phillips; A J Becker; B L Gallie
Journal:  Science       Date:  1988-09-30       Impact factor: 47.728

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma.

Authors:  V Blanquet; C Turleau; M S Gross-Morand; C Sénamaud-Beaufort; F Doz; C Besmond
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

9.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

10.  Patterns of risk of hereditary retinoblastoma and applications to genetic counselling.

Authors:  G J Draper; B M Sanders; P A Brownbill; M M Hawkins
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640
  10 in total
  5 in total

1.  Retinoblastoma: genetic testing versus conventional clinical screening in India.

Authors:  Biju Joseph; Mahesh Palanivelu Shanmugam; Madhuravasal Krishnan Srinivasan; Govindasamy Kumaramanickavel
Journal:  Mol Diagn       Date:  2004

2.  Genes and environment: effects on the development of second malignancies in retinoblastoma survivors.

Authors:  Amy C Schefler; Ruth A Kleinerman; David H Abramson
Journal:  Expert Rev Ophthalmol       Date:  2008-02-01

3.  Enhanced sensitivity for detection of low-level germline mosaic RB1 mutations in sporadic retinoblastoma cases using deep semiconductor sequencing.

Authors:  Zhao Chen; Kimberly Moran; Jennifer Richards-Yutz; Erik Toorens; Daniel Gerhart; Tapan Ganguly; Carol L Shields; Arupa Ganguly
Journal:  Hum Mutat       Date:  2013-12-20       Impact factor: 4.878

Review 4.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

5.  Retinoblastoma in India : microsatellite analysis and its application in genetic counseling.

Authors:  Vedam L Ramprasad; Jagadeesan Madhavan; Sakthivel Murugan; Jagadeesh Sujatha; Seshadri Suresh; Tarun Sharma; Govindasamy Kumaramanickavel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.